Cargando…

RAGE is a Potential Cause of Onset and Progression of Nonalcoholic Fatty Liver Disease

OBJECTIVE: Fatty liver is a rising global health concern, significantly increasing the burden of health care cost. Nonalcoholic fatty liver disease (NAFLD) has a correlation with metabolic syndrome and its complications. METHOD: We reviewed the literature regarding the mechanisms of developing NAFLD...

Descripción completa

Detalles Bibliográficos
Autores principales:	Asadipooya, Kamyar, Lankarani, Kamran B., Raj, Rishi, Kalantarhormozi, Mohammadreza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2019
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6766674/ https://www.ncbi.nlm.nih.gov/pubmed/31641351 http://dx.doi.org/10.1155/2019/2151302

Ejemplares similares

Oncogenic osteomalacia secondary to glomus tumor
por: Raj, Rishi, et al.
Publicado: (2021)

Adiponectin as a Protective Factor Against the Progression Toward Type 2 Diabetes Mellitus in Postmenopausal Women
por: Darabi, Hossein, et al.
Publicado: (2015)

Simvastatin Improves Microcirculatory Function in Nonalcoholic Fatty Liver Disease and Downregulates Oxidative and ALE-RAGE Stress
por: Pereira, Evelyn Nunes Goulart da Silva, et al.
Publicado: (2022)

Perspectives on youth‐onset nonalcoholic fatty liver disease
por: Castillo‐Leon, Eduardo, et al.
Publicado: (2020)

Delivery of Euthyroid Baby following Hyperthyroidism in Twin Gestation with Coexisting Complete Hydatidiform Mole
por: Raj, Rishi, et al.
Publicado: (2019)

Serum Soluble Receptor for AGE (sRAGE) Levels Are Associated With Unhealthy Lifestyle and Nonalcoholic Fatty Liver Disease
por: Ivancovsky-Wajcman, Dana, et al.
Publicado: (2019)

New-Onset Age of Nonalcoholic Fatty Liver Disease and Cancer Risk
por: Liu, Chenan, et al.
Publicado: (2023)

HMGB1-RAGE pathway drives peroxynitrite signaling-induced IBD-like inflammation in murine nonalcoholic fatty liver disease
por: Chandrashekaran, Varun, et al.
Publicado: (2017)

Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
por: Boutari, Chrysoula, et al.
Publicado: (2018)

Recent Progress in the Molecular Imaging of Nonalcoholic Fatty Liver Disease
por: Wegrzyniak, Olivia, et al.
Publicado: (2021)

The Chromatin Accessibility Landscape of Nonalcoholic Fatty Liver Disease Progression
por: Kang, Byeonggeun, et al.
Publicado: (2022)

Clinical Manifestations and Diagnosis of Nonalcoholic Fatty Liver Disease
por: Khoonsari, Mahmoodreza, et al.
Publicado: (2017)

Kcne2 deletion causes early-onset nonalcoholic fatty liver disease via iron deficiency anemia
por: Lee, Soo Min, et al.
Publicado: (2016)

Metabolic causes and consequences of nonalcoholic fatty liver disease (NAFLD)
por: Zarghamravanbakhsh, Paria, et al.
Publicado: (2021)

Nonalcoholic fatty liver disease in long-term survivors of childhood-onset craniopharyngioma
por: Jung, So Yoon, et al.
Publicado: (2017)

Nonalcoholic Fatty Liver Disease
por: Filipović, Branka, et al.
Publicado: (2018)

Nonalcoholic fatty liver disease
por: Bebawi, Emmanuel, et al.
Publicado: (2023)

The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease
por: Cazanave, Sophie, et al.
Publicado: (2017)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Effects of coenzyme Q10 supplementation on lipid profiles and liver enzymes of nonalcoholic fatty liver disease (NAFLD) patients: A systematic review and meta‐analysis of randomized controlled trials
por: Ardekani, Ali, et al.
Publicado: (2023)

The Role of Dendritic Cells in Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Almeda-Valdes, Paloma, et al.
Publicado: (2015)

Association Between Appendectomy and Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Nakano, Masakazu, et al.
Publicado: (2013)

Genetic Factors Involved in the Development and Progression of Nonalcoholic Fatty Liver Disease
por: AMZOLINI, A.M., et al.
Publicado: (2015)

Skeletal Muscle Dysfunction in the Development and Progression of Nonalcoholic Fatty Liver Disease
por: Altajar, Sarah, et al.
Publicado: (2020)

Research Progress on the Mechanism of Acupuncture Treatment for Nonalcoholic Fatty Liver Disease
por: Li, Bai, et al.
Publicado: (2022)

The Potential Mechanisms of Berberine in the Treatment of Nonalcoholic Fatty Liver Disease
por: Zhu, Xiaopeng, et al.
Publicado: (2016)

Potential Therapeutic Application of Estrogen in Gender Disparity of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Lee, Chanbin, et al.
Publicado: (2019)

Rodent Models of Nonalcoholic Fatty Liver Disease/Nonalcoholic Steatohepatitis
por: Imajo, Kento, et al.
Publicado: (2013)

Progression from Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis Cirrhosis Confirmed by Liver Histology after 14 Years
por: Kawanaka, Miwa, et al.
Publicado: (2020)

Liver osteopontin is required to prevent the progression of age‐related nonalcoholic fatty liver disease
por: Gómez‐Santos, Beatriz, et al.
Publicado: (2020)

Diabetes and Nonalcoholic Fatty Liver Disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Probiotics and Nonalcoholic Fatty liver Disease
por: Eslamparast, Tannaz, et al.
Publicado: (2013)

Sirtuins and nonalcoholic fatty liver disease
por: Nassir, Fatiha, et al.
Publicado: (2016)

History of Nonalcoholic Fatty Liver Disease
por: Lonardo, Amedeo, et al.
Publicado: (2020)

Nonalcoholic fatty liver disease and diabetes
por: Bellini, Maria Irene, et al.
Publicado: (2022)

IL-17 Signaling Accelerates the Progression of Nonalcoholic Fatty Liver Disease in Mice
por: Harley, Isaac TW, et al.
Publicado: (2014)

The impact of nonalcoholic fatty liver disease on chronic viral hepatitis – progression to cirrhosis
por: Olariu, Cristina, et al.
Publicado: (2013)

Steatohepatitis Is Not Associated with an Increased Risk for Fibrosis Progression in Nonalcoholic Fatty Liver Disease
por: Hagström, Hannes, et al.
Publicado: (2018)

Clinical course of nonalcoholic fatty liver disease: an assessment of severity, progression, and outcomes
por: Simeone, Jason C, et al.
Publicado: (2017)

Lactobacillus attenuates progression of nonalcoholic fatty liver disease by lowering cholesterol and steatosis
por: Lee, Na Young, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_8781tvt08ethh4cavpl1l8m4rl